Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Paloma, de la Cueva"'
Autor:
Magdalena B. Wozniak, Raquel Villuendas, James R. Bischoff, Carmen Blanco Aparicio, Juan F. Martínez Leal, Paloma de La Cueva, Ma Elena Rodriguez, Beatriz Herreros, Daniel Martin-Perez, Maria I. Longo, Marta Herrera, Miguel Á. Piris, Pablo L Ortiz-Romero
Publikováno v:
Haematologica, Vol 95, Iss 4 (2010)
Background Vorinostat (suberoylanilide hydroxamic acid, SAHA), an inhibitor of class I and II histone deacetylases, has been approved for the treatment of cutaneous T-cell lymphoma. In spite of emerging information on the effect of vorinostat in many
Externí odkaz:
https://doaj.org/article/28eee7d249f24154a5771a35c9a3f794
Autor:
Mohit Aggarwal, Margarita Sánchez-Beato, Gonzalo Gómez-López, Fátima Al-Shahrour, Nerea Martínez, Antonia Rodríguez, Elena Ruiz-Ballesteros, Francisca I. Camacho, Alberto Pérez-Rosado, Paloma de la Cueva, María J. Artiga, David G. Pisano, Eva Kimby, Joaquín Dopazo, Raquel Villuendas, Miguel A. Piris
Publikováno v:
Leukemia & Lymphoma. 50:1699-1708
Gene-expression profiling in B-cell lymphomas has provided crucial data on specific lymphoma types, which can contribute to the identification of essential lymphoma survival genes and pathways. In this study, the gene-expression profiling data of all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad5d136d882c19b3b4ea4b372bf7db87
https://doi.org/10.1080/10428190903189035
https://doi.org/10.1080/10428190903189035
Autor:
Miguel A. Piris, Paloma de la Cueva, Mónica García-Cosío, Lidia Sanchez-Verde, Reyes Arranz, Dolores Caballero, Jesús M. Hernández, Ana I. Sáez, Antonio José Sáez, David Alvarez, Carlos Grande, Jose A. Rodriguez, Eulogio Conde
Publikováno v:
Leukemia & Lymphoma. 50:571-581
The aim of the project was to identify biological variables in high-clinical-risk patients with diffuse large B-cell lymphoma (DLBCL), treated with risk-adapted therapies. The study was performed in a series of high-clinical-risk patients with DLBCL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4abdac0b37aa5ea2910433bcbf887ee0
https://doi.org/10.1080/10428190902785528
https://doi.org/10.1080/10428190902785528
Autor:
Javier Martínez-Botas, Miguel A. Lasunción, Antonio J. Ferruelo, Diego Gómez-Coronado, Carlos Fernández-Hernando, Sara Rodríguez-Acebes, Paloma de la Cueva
Publikováno v:
Biochemical and Biophysical Research Communications. 377:484-488
We addressed the ability of native, oxidized and acetylated low-density lipoproteins (nLDL, oxLDL and acLDL, respectively) and desmosterol to act as sources of sterol for the proliferation of J774A.1 macrophages. Treatment with 0.5 microM lovastatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae0c32a12ef6a95db3a59d71f0bbef2b
https://doi.org/10.1016/j.bbrc.2008.09.140
https://doi.org/10.1016/j.bbrc.2008.09.140
Autor:
Cezary Treda, Miguel A. Piris, Daniel Martín-Pérez, Mohit Aggarwal, Orlando Domínguez, Antonio Ruiz-Vela, Beatriz Herreros, Paloma de la Cueva
Publikováno v:
Blood. 111:1665-1676
Aberrant inhibition of B-cell receptor (BCR)-induced programmed cell death pathways is frequently associated with the development of human auto-reactive B-cell lymphomas. Here, we integrated loss-of-function, genomic, and bioinformatics approaches fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef650fca4c10b535b5f1893d5c833011
https://doi.org/10.1182/blood-2007-09-110601
https://doi.org/10.1182/blood-2007-09-110601
Autor:
José García-Laraña, Vicens Romagosa, Abel Sánchez-Aguilera, Juan F. García, Carmen Bellas, Mónica García-Cosío, Concepción Nicolás, Maria J Mestre, Lydia Sanchez-Verde, Miguel A. Piris, Alberto Fernández de Sevilla, Manuel M. Morente, Carlos Montalbán, Manuel F. Fresno, Pilar Sabin, Javier Menárguez, Mariano Provencio, Miguel Méndez, Paloma de la Cueva
Publikováno v:
Blood. 108:662-668
Around 20% to 30% of patients with Hodgkin lymphoma (HL) do not benefit from standard therapies and finally succumb to their disease. The factors that influence the outcome of HL have not been elucidated, underscoring the demand for the identificatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be2b1336cf0da1553aaa38b9e4cda64c
https://doi.org/10.1182/blood-2005-12-5125
https://doi.org/10.1182/blood-2005-12-5125
Autor:
Lydia Huerta, Emma Teixeiro, Angel Celdrán, Maria V.T. Lobo, Paloma de la Cueva, Miguel A. Vega, Rafael Bragado, Antonia Martín–Hidalgo, Natividad Ruiz–Velasco
Publikováno v:
Journal of Histochemistry & Cytochemistry. 49:1253-1260
The scavenger receptors CLA-1/SR-BI and CD36 interact with native and modified lipoproteins and with some anionic phospholipids. In addition, CD36 binds/transports long-chain free fatty acids. Recent biochemical evidences indicates that the rabbit CL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fb728a907cd97629aac1bb4ce3522a6
https://doi.org/10.1177/002215540104901007
https://doi.org/10.1177/002215540104901007
Autor:
Josefa, León, Jorge, Casado, Angel, Carazo, Laura, Sanjuán, Ana, Maté, Paloma, Muñoz de Rueda, Paloma, de la Cueva, Rosa, Quiles, Sergio, Ruíz, Angela, Ruíz-Extremera, Javier, Salmerón
Publikováno v:
Molecular carcinogenesis. 51(8)
Melatonin inhibits growth and invasive capacity of colon cancer cells in vitro through its membrane (MT1 and MT2) and/or nuclear receptors (RORα). Previous studies showed that this indoleamine is present in both the normal and colon cancer at simila
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a18832e19c5e178fb972284987ad012b
https://pubmed.ncbi.nlm.nih.gov/21809392
https://pubmed.ncbi.nlm.nih.gov/21809392
Autor:
Sara Rodríguez-Acebes, Paloma de la Cueva, Robert B. Rawson, Carlos Fernández-Hernando, Javier Martínez-Botas, Antonio J. Ferruelo, Diego Gómez-Coronado, Miguel A. Lasunción
Publikováno v:
The Biochemical journal. 420(2)
Cholesterol homoeostasis is critical for cell viability and proliferation. The SREBP (sterol regulatory element-binding protein) pathway is crucial for the maintenance of cholesterol homoeostasis. This pathway is controlled by cholesterol and cholest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9edf32d4dcb2c16945d943c5e479d1b9
https://pubmed.ncbi.nlm.nih.gov/19426142
https://pubmed.ncbi.nlm.nih.gov/19426142
Autor:
Sara Rodríguez‑Acebes, Paloma de la Cueva, Carlos Fernández‑Hernando, Antonio J. Ferruelo, Robert B. Rawson
Publikováno v:
Biochemical Journal; May2009, Vol. 420 Issue 2, p305-315, 11p